FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Teresa Cabrera

Research Profile

Chemicals & Drugs

Disorders

Physiology

Genes & Molecular Sequences

Genes, MHC Class I

Procedures

Immunotherapy

Co-author Network

Publications

TOP 3
Rafael Carretero; Alyson M Engle; Federico Garrido; Hui Liu; Francesco M Marincola; Jennifer Reinboth; Ana I Rodriguez; Ena Wang; Maria L Ascierto; Francisco M Camacho; Teresa Cabrera
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
Natalia Aptsiauri; Teresa Cabrera; Angel Garcia-Lora; Federico Garrido
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
Rafael Carretero; Jose Manuel Cozar; Natalia Aptsiauri; Teresa Cabrera; Hernani Gil; Isabel Maleno; Pablo Saenz-Lopez; Federico Garrido
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Teresa Cabrera (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rafael Carretero; Alyson M Engle; Federico Garrido; Hui Liu; Francesco M Marincola; Jennifer Reinboth; Ana I Rodriguez; Ena Wang; Maria L Ascierto; Francisco M Camacho; Teresa Cabrera
Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes.
International journal of cancer. Journal international du cancer 2012;131(2):387-95.
2012: Natalia Aptsiauri; Teresa Cabrera; Angel Garcia-Lora; Federico Garrido
Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
Cancer immunology, immunotherapy : CII 2012;61(5):739-45.
2011: Rafael Carretero; Jose Manuel Cozar; Natalia Aptsiauri; Teresa Cabrera; Hernani Gil; Isabel Maleno; Pablo Saenz-Lopez; Federico Garrido
Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells.
International journal of cancer. Journal international du cancer 2011;129(4):839-46.
2011: Mónica Bernal; Angel Concha; Pablo Sáenz-López; Ana Isabel Rodríguez; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello
Leukocyte infiltrate in gastrointestinal adenocarcinomas is strongly associated with tumor microsatellite instability but not with tumor immunogenicity.
Cancer immunology, immunotherapy : CII 2011;60(6):869-82.
2011: Isabel Maleno; Natalia Aptsiauri; Teresa Cabrera; Aurelia Gallego; Annette Paschen; Miguel A López-Nevot; Federico Garrido
Frequent loss of heterozygosity in the β2-microglobulin region of chromosome 15 in primary human tumors.
Immunogenetics 2011;63(2):65-71.
2010: Ana Belén García-Ruano; Rosa Méndez; José María Romero; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Analysis of HLA-ABC locus-specific transcription in normal tissues.
Immunogenetics 2010;62(11-12):711-9.
2010: Federico Garrido; Teresa Cabrera; Natalia Aptsiauri
"Hard" and "soft" lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy.
International journal of cancer. Journal international du cancer 2010;127(2):249-56.
2010: P Sáenz-López; Cécile Gouttefangeas; J Hennenlotter; Angel Concha; Isabel Maleno; Francisco Ruiz-Cabello; José Manuel Cózar; Miguel Tallada; A Stenzl; H-G Rammensee; Federico Garrido; Teresa Cabrera
Higher HLA class I expression in renal cell carcinoma than in autologous normal tissue.
Tissue antigens 2010;75(2):110-8.
2009: R Mendez; Natalia Aptsiauri; Ana Del Campo; Isabel Maleno; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido; Angel Garcia-Lora
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank.
Cancer immunology, immunotherapy : CII 2009;58(9):1507-15.
2008: Natalia Aptsiauri; Rafael Carretero; Angel Garcia-Lora; Luis Miguel Real; Teresa Cabrera; Federico Garrido
Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations.
Cancer immunology, immunotherapy : CII 2008;57(11):1727-33.
2008: Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis Miguel Real; Federico Garrido; Teresa Cabrera
Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.
Immunogenetics 2008;60(8):439-47.
2007: Natalia Aptsiauri; Teresa Cabrera; Graham Pawelec; Cécile Gouttefangeas; Evelyna Derhovanessian; Federico Garrido; Angel Garcia-Lora
International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain.
Cancer immunology, immunotherapy : CII 2007;56(8):1311-22.
2007: Teresa Cabrera; Ester Lara; José María Romero; Isabel Maleno; Luis Miguel Real; Francisco Ruiz-Cabello; Pedro Valero; Francisco M Camacho; Federico Garrido
HLA class I expression in metastatic melanoma correlates with tumor development during autologous vaccination.
Cancer immunology, immunotherapy : CII 2007;56(5):709-17.
2007: Teresa Cabrera; Isabel Maleno; Antonia Collado; Miguel A Lopez-Nevot; Brian Tait; Federico Garrido
Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms.
Tissue antigens 2007;69 Suppl 1():264-8.
2007: Derek Middleton; Jose R Vilchez; Teresa Cabrera; Ashley Meenagh; Fionnuala Williams; Iris A Halfpenny; Isabel Maleno; Francisco Ruiz-Cabello; Miguel A Lopez-Nevot; Federico Garrido
Analysis of KIR gene frequencies in HLA class I characterised bladder, colorectal and laryngeal tumours.
Tissue antigens 2007;69(3):220-6.
2007: Natalia Aptsiauri; Teresa Cabrera; Rosa Mendez; Angel Garcia-Lora; Francisco Ruiz-Cabello; Federico Garrido
Role of altered expression of HLA class I molecules in cancer progression.
Advances in experimental medicine and biology 2007;601():123-31.
2007: Natalia Aptsiauri; Teresa Cabrera; Angel Garcia-Lora; Miguel A Lopez-Nevot; Francisco Ruiz-Cabello; Federico Garrido
MHC class I antigens and immune surveillance in transformed cells.
International review of cytology 2007;256():139-89.
2006: José María Romero; Natalia Aptsiauri; F Vazquez; Jose Manuel Cozar; Julia Canton; Teresa Cabrera; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Analysis of the expression of HLA class I, proinflammatory cytokines and chemokines in primary tumors from patients with localized and metastatic renal cell carcinoma.
Tissue antigens 2006;68(4):303-10.
2006: Isabel Maleno; José María Romero; Teresa Cabrera; Laura Paco; Natalia Aptsiauri; Jose Manuel Cozar; Miguel Tallada; Miguel A López-Nevot; Federico Garrido
LOH at 6p21.3 region and HLA class I altered phenotypes in bladder carcinomas.
Immunogenetics 2006;58(7):503-10.
2005: José Manuel Cózar; Julia Canton; Miguel Tallada; Angel Concha; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello Osuna
Analysis of NK cells and chemokine receptors in tumor infiltrating CD4 T lymphocytes in human renal carcinomas.
Cancer immunology, immunotherapy : CII 2005;54(9):858-66.
2005: José María Romero; Pilar Jiménez; Teresa Cabrera; José Manuel Cózar; Susana Pedrinaci; Miguel Tallada; Federico Garrido; Francisco Ruiz-Cabello
Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer.
International journal of cancer. Journal international du cancer 2005;113(4):605-10.
2004: Ignacio Algarra; Angel García-Lora; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.
Cancer immunology, immunotherapy : CII 2004;53(10):904-10.
2004: Isabel Maleno; Carmen Cabrera; Teresa Cabrera; Laura Paco; Miguel A López-Nevot; Antonia Collado; Antonio Ferrón; Federico Garrido
Distribution of HLA class I altered phenotypes in colorectal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Immunogenetics 2004;56(4):244-53.
2003: Teresa Cabrera; Isabel Maleno; Miguel A Lopez-Nevot; Maximino Redondo; Maria Angustias Fernandez; Antonia Collado; Federico Garrido
High frequency of HLA-B44 allelic losses in human solid tumors.
Human immunology 2003;64(10):941-50.
2003: Teresa Cabrera; G Pedrajas; Jose Manuel Cozar; A Garrido; J Vicente; Miguel Tallada; Federico Garrido
HLA class I expression in bladder carcinomas.
Tissue antigens 2003;62(4):324-7.
2003: C M Cabrera; Pilar Jiménez; Teresa Cabrera; C Esparza; Francisco Ruiz-Cabello; Federico Garrido
Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Tissue antigens 2003;61(3):211-9.
2003: Teresa Cabrera; Miguel A López-Nevot; José Juan Gaforio; Francisco Ruiz-Cabello; Federico Garrido
Analysis of HLA expression in human tumor tissues.
Cancer immunology, immunotherapy : CII 2003;52(1):1-9.
2002: Isabel Maleno; Miguel A López-Nevot; Teresa Cabrera; José Salinero; Federico Garrido
Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21.
Cancer immunology, immunotherapy : CII 2002;51(7):389-96.
2002: Francisco Ruiz-Cabello; Teresa Cabrera; Miguel A Lopez-Nevot; Federico Garrido
Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy.
Seminars in cancer biology 2002;12(1):15-24.
2001: Pilar Jiménez; Teresa Cabrera; R Méndez; C Esparza; Jose Manuel Cozar; Miguel Tallada; Miguel A López-Nevot; Francisco Ruiz-Cabello; Federico Garrido
A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*0301 allele in a prostate carcinoma cell line.
Immunogenetics 2001;53(7):606-10.
2000: Luis Ramal; Isabel Maleno; Teresa Cabrera; Antonia Collado; A Ferron; Miguel A Lopez-Nevot; Federico Garrido
Molecular strategies to define HLA haplotype loss in microdissected tumor cells.
Human immunology 2000;61(10):1001-12.
2000: Teresa Cabrera; J Salinero; Maria Angustias Fernandez; A Garrido; J Esquivias; Federico Garrido
High frequency of altered HLA class I phenotypes in laryngeal carcinomas.
Human immunology 2000;61(5):499-506.
2000: Pilar Jimenez; Julia Cantón; Angel Concha; Teresa Cabrera; M Fernández; Luis Miguel Real; A García; A Serrano; Federico Garrido; Francisco Ruiz-Cabello
Microsatellite instability analysis in tumors with different mechanisms for total loss of HLA expression.
Cancer immunology, immunotherapy : CII 2000;48(12):684-90.
2000: M A Fernández; Francisco Ruiz-Cabello; Maria R Oliva; Teresa Cabrera; Pilar Jimenez; Miguel A López-Nevot; Federico Garrido
Beta2-microglobulin gene mutation is not a common mechanism of HLA class I total loss in human tumors.
International journal of clinical & laboratory research 2000;30(2):87-92.
2000: Ignacio Algarra; Teresa Cabrera; Federico Garrido
The HLA crossroad in tumor immunology.
Human immunology 2000;61(1):65-73.
1999: Pilar Jiménez; Julia Cantón; Antonia Collado; Teresa Cabrera; A Serrano; Luis Miguel Real; A García; Francisco Ruiz-Cabello; Federico Garrido
Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors.
International journal of cancer. Journal international du cancer 1999;83(1):91-7.
1999: Luis Miguel Real; Teresa Cabrera; Julia Canton; R Oliva; Francisco Ruiz-Cabello; Federico Garrido
Looking for HLA-G expression in human tumours.
Journal of reproductive immunology 1999;43(2):263-73.
1999: Luis Miguel Real; Teresa Cabrera; Antonia Collado; Pilar Jimenez; A Garcia; Francisco Ruiz-Cabello; Federico Garrido
Expression of HLA G in human tumors is not a frequent event.
International journal of cancer. Journal international du cancer 1999;81(4):512-8.
1999: Ignacio Algarra; José Juan Gaforio; Teresa Cabrera; Antonia Collado; Federico Garrido
The biological consequences of altered MHC class I expression in tumours.
Journal of biological regulators and homeostatic agents 1999;13(2):90-6.
1998: R Benitez; Danièle Godelaine; Miguel A Lopez-Nevot; Francis Brasseur; P Jiménez; M Marchand; Maria R Oliva; Nicolas van Baren; Teresa Cabrera; G Andry; C Landry; Francisco Ruiz-Cabello; Thierry Boon; Federico Garrido
Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides.
Tissue antigens 1998;52(6):520-9.
1998: Teresa Cabrera; Antonia Collado; Maria Angustias Fernandez; A Ferron; J Sancho; Francisco Ruiz-Cabello; Federico Garrido
High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas.
Tissue antigens 1998;52(2):114-23.
1997: Federico Garrido; Francisco Ruiz-Cabello; Teresa Cabrera; JJ Pérez-Villar; M López-Botet; Margaret Duggan-Keen; Peter L Stern
Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.
Immunology today 1997;18(2):89-95.
1996: Teresa Cabrera; M Angustias Fernandez; A Sierra; A Garrido; A Herruzo; Agustín Escobedo; Angels Fabra; Federico Garrido
High frequency of altered HLA class I phenotypes in invasive breast carcinomas.
Human immunology 1996;50(2):127-34.
1996: Eduardo Abril; R E Mendez; A García; A Serrano; Teresa Cabrera; Federico Garrido; Francisco Ruiz-Cabello
Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon.
Tissue antigens 1996;47(5):391-8.
1995: Angel Concha; Francisco Ruiz-Cabello; Teresa Cabrera; Francisco F Nogales; Antonia Collado; Federico Garrido
Different patterns of HLA-DR antigen expression in normal epithelium, hyperplastic and neoplastic malignant lesions of the breast.
European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics 1995;22(4):299-310.
1995: Federico Garrido; Teresa Cabrera; M A Lopez-Nevot; Francisco Ruiz-Cabello
HLA class I antigens in human tumors.
Advances in cancer research 1995;67():155-95.
1993: F Garrido; Teresa Cabrera; Angel Concha; S Glew; Francisco Ruiz-Cabello; Peter L Stern
Natural history of HLA expression during tumour development.
Immunology today 1993;14(10):491-9.
1993: L M Torres; Teresa Cabrera; Angel Concha; Maria R Oliva; Francisco Ruiz-Cabello; Federico Garrido
HLA class I expression and HPV-16 sequences in premalignant and malignant lesions of the cervix.
Tissue antigens 1993;41(2):65-71.
1992: Teresa Cabrera; V Garrido; Angel Concha; J Martín; J Esquivias; Maria R Oliva; Francisco Ruiz-Cabello; S Serrano; Federico Garrido
HLA molecules in basal cell carcinoma of the skin.
Immunobiology 1992;185(5):440-52.
1992: S S Glew; Margaret Duggan-Keen; Teresa Cabrera; Peter L Stern
HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Cancer research 1992;52(14):4009-16.
1991: J E Fernández; Angel Concha; Antonia Aránega; Francisco Ruiz-Cabello; Teresa Cabrera; Federico Garrido
HLA class I and II expression in rhabdomyosarcomas.
Immunobiology 1991;182(5):440-8.
1991: Teresa Cabrera; Angel Concha; Francisco Ruiz-Cabello; Federico Garrido
Loss of HLA heavy chain and beta 2-microglobulin in HLA negative tumours.
Scandinavian journal of immunology 1991;34(2):147-52.
1991: Maximino Redondo; Francisco Ruiz-Cabello; Angel Concha; Teresa Cabrera; M Pérez-Ayala; Maria R Oliva; Federico Garrido
Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Cancer research 1991;51(9):2463-8.
1991: Angel Concha; Francisco Esteban; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Tumor aggressiveness and MHC class I and II antigens in laryngeal and breast cancer.
Seminars in cancer biology 1991;2(1):47-54.
1991: Angel Concha; Teresa Cabrera; Francisco Ruiz-Cabello; Federico Garrido
Can the HLA phenotype be used as a prognostic factor in breast carcinomas?
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():146-54.
1991: Francisco Ruiz-Cabello; M Perez-Ayala; O Gomez; Maximino Redondo; Angel Concha; Teresa Cabrera; Federico Garrido
Molecular analysis of MHC-class-I alterations in human tumor cell lines.
International journal of cancer. Supplement = Journal international du cancer. Supplement 1991;6():123-30.
1990: Maria R Oliva; Teresa Cabrera; J Esquivias; M Perez-Ayala; Maximino Redondo; Francisco Ruiz-Cabello; Federico Garrido
K-ras mutations (codon 12) are not involved in down-regulation of MHC class-I genes in colon carcinomas.
International journal of cancer. Journal international du cancer 1990;46(3):426-31.
1990: M Pérez-Ayala; Francisco Ruiz-Cabello; Francisco Esteban; Angel Concha; Maximino Redondo; Maria R Oliva; Teresa Cabrera; Federico Garrido
Presence of HPV 16 sequences in laryngeal carcinomas.
International journal of cancer. Journal international du cancer 1990;46(1):8-11.
1990: J Gutierrez; Francisco Ruiz-Cabello; M A López Nevot; Teresa Cabrera; J Esquivias; Federico Garrido
Class II HLA antigen expression in familial polyposis coli is related to the degree of dysplasia.
Immunobiology 1990;180(2-3):138-48.
1989: A Ferron; M Perez-Ayala; Angel Concha; Teresa Cabrera; Maximino Redondo; Maria R Oliva; Francisco Ruiz-Cabello; Federico Garrido
MHC class I and II antigens on gastric carcinomas and autologous mucosa.
Journal of immunogenetics 1989;16(4-5):413-23.
1987: J Gutierrez; M A López-Nevot; Teresa Cabrera; R Oliva; J Esquivias; Francisco Ruiz-Cabello; Federico Garrido
Class I and II HLA antigen distribution in normal mucosa, adenoma and colon carcinoma: relation with malignancy and invasiveness.
Experimental and clinical immunogenetics 1987;4(3):144-52.
1986: M Pérez; Teresa Cabrera; M A Lopez Nevot; M Gomez; F Peran; Francisco Ruiz-Cabello; Federico Garrido
Heterogeneity of the expression of class I and II HLA antigens in human breast carcinoma.
Journal of immunogenetics 1986;13(2-3):247-53.